Inside Precision Medicine February 6, 2024
Jonathan Smith

Comprehensive genomic profiling (CGP) is ushering in an era of precision medicine by making it easier to treat tumors in a targeted manner. Check out 10 leading specialists providing these game-changing services.

As increasingly targeted cancer treatments enter the market, demand is growing for ways to quickly learn which patients might benefit the most from these therapies.

Genetic testing has made it possible to profile tumor-associated biomarkers using tissue biopsies, shedding light on how to better fight cancers. However, many genetic tests are limited to single genes or a few types of mutations.

CGP is an approach designed to screen hundreds of genetic biomarkers at once using a single next-generation sequencing (NGS) assay. It is often able to pick up...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption
Sylvester Cancer Center Launches Precision-Medicine Focused Brain Tumor Institute
Largest GWAS for Breast Cancer in Women of African Ancestry Reveals Key Variants
New Study Links Ribosomal DNA Copy Number with Disease Risk
Navigating the Complexities of Payment for Genetic Testing

Share This Article